Ultomiris

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 25682-028
  • Package NDC 25682-028-01
  • Application number BLA761108
  • SPL ID d58a5077-e563-4aad-990b-82303eedf048
  • SPL set ID a9a590d9-0217-43c7-908d-e62a71279791
  • UNII C3VX249T6L
  • RxCUI 2461134
  • RxCUI 2461136
  • RxCUI 2461139
  • RxCUI 2461140

What the source publishes

Labeler
Alexion Pharmaceuticals Inc.
Active ingredients
ravulizumab
Form
SOLUTION, CONCENTRATE
Routes
INTRAVENOUS
Administrative status
present-in-source-snapshot
Marketing status
BLA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:25682-028_d58a5077-e563-4aad-990b-82303eedf048
{
  "name": "Ultomiris",
  "splId": "d58a5077-e563-4aad-990b-82303eedf048",
  "labels": [
    {
      "setId": "a9a590d9-0217-43c7-908d-e62a71279791",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a9a590d9-0217-43c7-908d-e62a71279791",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a9a590d9-0217-43c7-908d-e62a71279791"
    }
  ],
  "routes": [
    "INTRAVENOUS"
  ],
  "labeler": "Alexion Pharmaceuticals Inc.",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "1 VIAL, GLASS in 1 CARTON (25682-028-01)  / 11 mL in 1 VIAL, GLASS",
      "package_ndc": "25682-028-01",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20201009"
    }
  ],
  "productId": "25682-028_d58a5077-e563-4aad-990b-82303eedf048",
  "useDomain": "unknown",
  "dosageForm": "SOLUTION, CONCENTRATE",
  "productNdc": "25682-028",
  "deaSchedule": null,
  "genericName": "ravulizumab",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "RAVULIZUMAB",
      "strength": "1100 mg/11mL"
    }
  ],
  "applicationNumber": "BLA761108",
  "marketingCategory": "BLA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20201009",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000175575",
      "N0000175974"
    ],
    "unii": [
      "C3VX249T6L"
    ],
    "rxcui": [
      "2461134",
      "2461136",
      "2461139",
      "2461140"
    ],
    "spl_set_id": [
      "a9a590d9-0217-43c7-908d-e62a71279791"
    ],
    "pharm_class_epc": [
      "Complement Inhibitor [EPC]"
    ],
    "pharm_class_moa": [
      "Complement Inhibitors [MoA]"
    ],
    "manufacturer_name": [
      "Alexion Pharmaceuticals Inc."
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:25682-028_d58a5077-e563-4aad-990b-82303eedf048"